Nova (NVMI) 6-K Current report (foreign)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2022
Commission File No.: 000-30668

NOVA LTD.

(Translation of registrant’s name into English)

5 David Fikes Street, Rehovot, Israel

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ 

Attached hereto and incorporated by way of reference herein is a press release issued by the Registrant and entitled: “Nova Reports Record Results for First Quarter of 2022”.

The GAAP financial statements tables included in the press release attached hereto are hereby incorporated by reference into the Registrant’s registration statements on Form S-8, filed with the Securities and Exchange Commission on the following dates: November 5, 2007 (File No. 333-147140); October 25, 2012 (File No. 333-184585), March 6, 2015 (File No. 333-202550); and August 25, 2017 (File No. 333-220158).

SIGNATURES

 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

Date: May 12, 2022

NOVA LTD.

(Registrant)

By: /s/ Dror David

—————————————

Dror David

Chief Financial Officer

Company Contact:

Dror David, Chief Financial Officer

Tel: +972-73-229-5760

E-mail - investors@novami.com

Nova website link - https://www.novami.com/

Investor Relations Contact:

Miri Segal MS-IR LLC

Tel: +917-607-8654

E-mail - msegal@ms-ir.com

Nova Reports Record Results for First Quarter of 2022

Outperforms Guidance, Posts Record Revenue and EPS

Rehovot, Israel, May 12, 2022 - Nova (Nasdaq: NVMI) today announced financial results for the first quarter ended March 31, 2022.

First Quarter 2022 Highlights:

• Record quarterly revenue of $134.0 million, exceeding the high end of a guidance of $132 million. Up 59% year over year

• Record GAAP net income of $34.2 million, or $1.07 per diluted share, exceeding the high end of a guidance of $0.96. Up 78% year over year on a per-share basis

• Record non-GAAP net income of $41.5 million, or $1.30 per diluted share, exceeding the high end of a guidance of $1.14. Up 86% year over year on a per-share basis

• Diversified geographic contributions led by China quarterly record revenue

• Strong customer mix driven by five major customers contributing over 10% each to products revenue, including the world leading IDM

GAAP Results ($K)

	Q1 2022	Q4 2021	Q1 2021
Revenues	$133,957	$121,521	$84,133
Net Income	$34,162	$22,226	$17,616
Earnings per Diluted Share	$1.07	$0.73	$0.60

Non-GAAP Results ($K)

	Q1 2022	Q4 2021	Q1 2021
Net Income	$ 41,487	$32,752	$20,485
Earnings per Diluted Share	$ 1.30	$1.08	$0.70

A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements included in this release. See also "Use of Non-GAAP Adjusted Financial Measures" section.

Management Comments

"Nova delivered a robust opening for 2022, outperforming guidance and locking down eight consecutive quarters of revenue growth. Our remarkable performance was driven by our burgeoning position across various industry sectors and technology nodes,” commented Eitan Oppenhaim, President and Chief Executive Officer. “Following the ancosys acquisition, this is the first quarter that we are embedding chemical metrology sales results into our consolidated reporting. During the quarter, we continued to integrate ancosys as a division into Nova, developing a strong pipeline of products and opportunities in both the front-end and back-end semiconductor processes. The demand for Nova’s solutions across dimensional, materials and chemical applications, continues to be strong and along with our record quarterly bookings and yearly backlog, we expect to continue our solid growth this year as well.“

2022 Second Quarter Financial Outlook

Management provided an outlook for the second quarter, the period ending June 30, 2022. Based on current estimates, management expects:

• $133 million to $141 million in revenue

• $0.82 to $0.96 in diluted GAAP EPS

• $1.09 to $1.23 in diluted non-GAAP EPS

2022 First Quarter Results

Total revenues for the first quarter of 2022 were $134.0 million, an increase of 10% compared with the fourth quarter of 2021 and an increase of 59% compared with the first quarter of 2021.

Gross margin in the first quarter of 2022 was 57%, compared with 56% in the fourth quarter of 2021 and 57% in the first quarter of 2021.

Operating expenses in the first quarter of 2022 were $39.0 million, compared with $38.4 million in the fourth quarter of 2021 and $28.2 million in the first quarter of 2021.

On a GAAP basis, the Company reported net income of $34.2 million, or $1.07 per diluted share, in the first quarter of 2022. This is compared with net income of $22.2 million, or $0.73 per diluted share, in the fourth quarter of 2021, and net income of $17.6 million, or $0.60 per diluted share, in the first quarter of 2021.

On a non-GAAP basis, the Company reported net income of $41.5 million, or $1.30 per diluted share, in the first quarter of 2022. This is compared with net income of $32.8 million, or $1.08 per diluted share, in the fourth quarter of 2021, and net income of $20.5 million, or $0.70 per diluted share, in the first quarter of 2021.

Conference Call Information

Nova will host a conference call today, May 12, 2022, at 8:30 a.m. Eastern Time, to discuss the financial results and outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

U.S. TOLL-FREE Dial-in Number: 1-800-239-9838

ISRAEL TOLL-FREE Dial-in Number: 1-809-407-724

INTERNATIONAL Dial-in Number: 1-323-794-2551

At:

8:30 a.m. Eastern Time

5:30 a.m. Pacific Time

3:30 p.m. Israel Time

The conference call will also be webcast live from a Link on Nova's website at https://www.novami.com/investors/events/.

A replay of the conference call will be available from May 12, 2022, at 11:30 a.m. Eastern Time to May 19, 2022, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers:

Replay Dial-in TOLL-FREE: 1-844-512-2921

Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-6671

Replay Pin Number: 2902650

A replay will also be available for 90 days on Nova's website at https://www.novami.com/investors/events/.

About Nova

Nova is a leading innovator and key provider of material, optical and chemical metrology solutions for advanced process control in semiconductor manufacturing. Nova delivers continuous innovation by providing state-of-the-art high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova’s product portfolio, which combines high-precision hardware and cutting-edge software, provides its customers with deep insight into developing and producing the most advanced semiconductor devices. Nova’s unique capability to deliver innovative solutions enables its customers to improve performance, enhance product yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices worldwide. Additional information may be found at Nova’s website link - https://www.novami.com/.

Nova is traded on the Nasdaq and TASE, Nasdaq ticker symbol NVMI.

Use of Non-GAAP Adjusted Financial Measures

This press release provides financial measures that exclude amortization of acquired intangible assets, acquisition related expenses, inventory step-up and contingent consideration revaluation, stock-based compensation expenses, revaluation of operating lease liabilities, amortization of debt discount and issuance costs, tax effect of non-GAAP adjustment and taxes attributed to one-time elective tax settlement, as applicable, and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhance management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allow greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: catastrophic events such as the outbreak of COVID-19; increased information technology security threats and sophisticated computer crime; foreign political and economic risks; changes in U.S. trade policies; inability to protect our intellectual property; open source technology exposure; failure to compete effectively or to respond to the rapid technological changes; consolidation in our industry; difficulty in predicting the length and strength of any downturn or expansion period of the market we target; factors that adversely affect the pricing and demand for our product lines; dependency on a small number of large customers; dependency on a single manufacturing facility per product line; dependency on a limited number of suppliers; difficulty in integrating current or future acquisitions; lengthy sales cycle and customer delays in orders; political, economic, and military instability in Israel; risks related to our convertible notes; currency fluctuations; and quarterly fluctuations in our operating results. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2021 filed with the Securities and Exchange Commission on March 1, 2022. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Ltd. does not assume any obligation to update the forward-looking information contained in this press release.

(Tables to Follow)

NOVA LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands) - (Unaudited)

	As of
	March 31, 2022		December 31, 2021
ASSETS
Current assets
Cash and cash equivalents		105,193		126,698
Short-term interest-bearing bank deposits		172,264		221,897
Marketable securities		63,425		61,568
Trade accounts receivable, net		77,985		68,446
Inventories		96,193		78,665
Other current assets		25,116		9,242
Total current assets		540,176		566,516
Non-current assets
Marketable securities		132,011		137,415
Interest-bearing bank deposits		3,595		3,672
Restricted interest-bearing bank deposits		1,602		1,600
Deferred tax assets		9,448		6,161
Severance pay funds		1,308		1,327
Operating lease right-of-use assets		45,809		30,627
Property and equipment, net		44,367		34,460
Intangible assets, net		49,308		2,601
Goodwill		50,540		20,114
Other long-term assets		744		661
Total non-current assets		338,732		238,638
Total assets		878,908		805,154
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Convertible senior notes, net		195,432		183,037
Trade accounts payable		35,973		36,218
Deferred revenues		14,583		15,338
Operating lease current liabilities		5,897		4,452
Other current liabilities		59,775		48,885
Total current liabilities		311,660		287,930
Non-current liabilities
Accrued severance pay		3,728		3,686
Operating lease long-term liabilities		47,293		33,450
Long-term deferred tax liability		13,743		-
Other long-term liabilities		6,936		6,334
Total non-current liabilities		71,700		43,470
Shareholders' equity		495,548		473,754
Total liabilities and shareholders' equity		878,908		805,154

NOVA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 (U.S. dollars in thousands, except per share data) - (Unaudited)

	Three months ended March 31,
	2022		2021
Revenues:
Products		109,912		66,283
Services		24,045		17,850
Total revenues		133,957		84,133
Total cost of revenues		57,807		36,203
Gross profit		76,150		47,930
Operating expenses:
Research and development, net		19,129		14,518
Sales and marketing		12,246		9,540
General and administrative		6,056		3,539
Amortization of intangible assets		1,613		575
Total operating expenses		39,044		28,172
Operating income		37,106		19,758
Financing income, net		1,218		424
Income before taxes on income		38,324		20,182
Income tax expenses		4,162		2,566
Net income for the period		34,162		17,616
Earnings per share:
Basic		1.20		0.62
Diluted		1.07		0.60
Shares used in calculation of earnings per share  (in thousands):
Basic		28,579		28,214
Diluted		31,968		29,306

NOVA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands) - (Unaudited)

	Three months ended March 31,
	2022			2021
Cash flows from operating activities:
Net income		34,162			17,616
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property and equipment		2,035			1,579
Amortization of intangible assets		1,613			575
Amortization of premium and accretion of discount on marketable securities, net		829			-
Amortization of debt discount and issuance costs		320			1,034
Share-based compensation		3,860			2,222
Net effect of exchange rate fluctuation		793			362
Changes in assets and liabilities:
Trade accounts receivables, net		470			3,494
Inventories		(6,898	)		(4,417	)
Other current and long-term assets		(15,996	)		(1,162	)
Deferred tax assets, net		(2,609	)		(598	)
Operating lease right-of-use assets		912			406
Trade accounts payables		(1,941	)		439
Deferred revenues		(744	)		9,021
Operating lease liabilities		(806	)		(1,266	)
Other current and long-term liabilities		(3,151	)		3,718
Accrued severance pay, net		61			(38	)
Net cash provided by operating activities		12,910			32,985
Cash flows from investment activities:
Acquisition of subsidiary, net of acquired cash		(78,469	)		-
Change in short-term and long-term interest-bearing bank deposits		49,632			(55,805	)
Investment in marketable securities		(16,836	)		-
Proceeds from maturities of marketable securities		15,770			-
Purchase of property and equipment		(3,718	)		(488	)
Net cash used in investing activities		(33,621	)		(56,293	)
Net cash provided by financing activities		-			-
Effect of exchange rate fluctuations on cash and cash equivalents		(794	)		(238	)
Changes in cash and cash equivalents		(21,505	)		(23,546	)
Cash and cash equivalents - beginning of period		126,698			232,304
Cash and cash equivalents - end of period		105,193			208,758

NOVA LTD.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(U.S. dollars in thousands, except percentage and per share data) - (Unaudited)

	Three months ended
	March 31, 2022			December 31, 2021			March 31, 2021
GAAP gross profit		76,150			68,249			47,930
Stock-based compensation*		883			803			418
Acquisition-related inventory step-up		2,606			-			-
Non-GAAP gross profit		79,639			69,052			48,348
GAAP gross margin as a percentage of revenues		57	%		56	%		57	%
Non-GAAP gross margin as a percentage of revenues		59	%		57	%		57	%
GAAP operating income		37,106			29,893			19,758
Stock-based compensation*		3,860			3,496			2,222
Acquisition-related inventory step-up		2,606			-			-
Acquisition-related expenses and contingent      consideration revaluation		1,355			999			-
Amortization of acquired intangible assets		1,613			735			575
Non-GAAP operating income		46,540			35,123			22,555
GAAP operating margin as a percentage of revenues		28	%		25	%		23	%
Non-GAAP operating margin as a percentage of revenues		35	%		29	%		27	%
GAAP net income		34,162			22,226			17,616
Stock-based compensation*		3,860			3,496			2,222
Acquisition-related inventory step-up		2,606			-			-
Acquisition-related expenses and contingent      consideration revaluation		1,355			999			-
Amortization of acquired intangible assets		1,613			735			575
Amortization of debt discount and issuance costs		320			1,075			1,034
Revaluation of operating lease liabilities		(546	)		907			(860	)
Tax effect of non-GAAP adjustments		(1,883	)		(402	)		(102	)
Taxes attributed to one-time elective tax settlement		-			3,716			-
Non-GAAP net income		41,487			32,752			20,485
GAAP basic earnings per share		1.20			0.78			0.62
Non-GAAP basic earnings per share		1.45			1.15			0.73
GAAP diluted earnings per share		1.07			0.73			0.60
Non-GAAP diluted earnings per share		1.30			1.08			0.70
Shares used for calculation of earnings per share (in thousands):
Basic		28,579			28,539			28,214
Diluted		31,968			30,285			29,306

* Stock-based compensation for the three months ended March 31, 2022 included in – Cost of revenues - 883; Research and development, net – 1,525; Sales and marketing – 786; General and administrative – 666

NOVA LTD.
SUPPLEMENTAL INFORMATION - RECONCILIATION OF SECOND QUARTER 2022
GAAP TO NON-GAAP GUIDANCE

(Unaudited)

	Low			High
Estimated GAAP net income per diluted share		0.82			0.96
Estimated non-GAAP items:
Stock-based compensation		0.13			0.13
Amortization of acquired intangible assets		0.06			0.06
Acquisition-related expenses and contingent      consideration revaluation		0.07			0.07
Acquisition-related inventory step-up		0.01			0.01
Amortization of issuance costs		0.01			0.01
Tax effect of non-GAAP adjustments		(0.01	)		(0.01	)
Estimated non-GAAP net income per diluted share		1.09			1.23